Skip to main content

Table 1 Characteristics of ART patients in central Kenya between 2004 and 2012

From: Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya

Participant characteristics

Total

Retained

LTFU

Dead

p value

n (%)

31,346 (100.0)

21,576 (68.8)

8495 (27.1)

1275 (4.1)

n (%)

n (%)

n (%)

n (%)

Age at enrollment (N = 31,346)

    

 < 0.001

 0–4

1533 (4.9)

1078 (5.0)

417 (4.9)

38 (3.0)

 

 5–9

1466 (4.7)

1100 (5.1)

323 (3.8)

43 (3.4)

 

 10–14

842 (2.7)

621 (2.9)

189 (2.2)

32 (2.5)

 

 15–19

500 (1.6)

342 (1.6)

147 (1.7)

11 (0.9)

 

 20–35

11,630 (37.1)

7534 (34.9)

3659 (43.1)

437 (34.3)

 

 36–50

12,422 (39.6)

8822 (40.9)

3061 (36.0)

539 (42.3)

 

 51 and above

2953 (9.4)

2079 (9.6)

699 (8.2)

175 (13.7)

 

Sex, (n = 31,346)

    

 < 0.001

 Male

10,791 (34.4)

7208 (33.4)

3002 (35.3)

581 (45.6)

 

 Female

20,555 (65.6)

14,368 (66.6)

5493 (64.7)

694 (54.4)

 

Marital status (n = 27,497)

    

 < 0.001

 Single

6964 (25.3)

4641 (24.4)

1973 (27.0)

350 (30.9)

 

 Married

12,622 (45.9)

9045 (47.5)

3144 (43.0)

433 (38.3)

 

 Divorced

4554 (16.6)

2949 (15.5)

1402 (19.2)

203 (17.9)

 

 Widowed

3357 (12.2)

2421 (12.7)

790 (10.8)

146 (12.9)

 

Regimen (n = 29,192)

    

 < 0.001

 D4T

14,823 (50.8)

9861 (48.6)

4200 (54.3)

762 (64.1)

 

 AZT

6363 (21.8)

4642 (22.9)

1508 (19.5)

213 (17.9)

 

 TDF

6578 (22.5)

4764 (23.5)

1631 (21.1)

183 (15.4)

 

 ABC

1428 (4.9)

1007 (5.0)

391 (5.1)

30 (2.5)

 

WHO stage at enrollment (n = 29,623)

    

 < 0.001

 Stage 1

5471 (18.5)

4082 (19.9)

1303 (16.4)

86 (7.1)

 

 Stage 2

10,622 (35.9)

7646 (37.3)

2663 (33.6)

313 (25.7)

 

 Stage 3

11,523 (38.9)

7637 (37.3)

3261 (41.2)

625 (51.3)

 

 Stage 4

2007 (6.8)

1118 (5.5)

695 (8.8)

194 (15.9)

 

TB status (n = 29,262)

    

 < 0.001

 No TB signs

27,828 (95.1)

20,087 (98.7)

6898 (88.8)

843 (73.8)

 

 Presumptive TB

289 (1.0)

90 (0.4)

124 (1.6)

75 (6.6)

 

 On TB TX

1145 (3.9)

176 (0.9)

745 (9.6)

224 (19.6)

 

ART cohort (n = 31,346)

    

 < 0.001

 2004

430 (1.4)

285 (1.3)

137 (1.6)

8 (0.6)

 

 2005

1294 (4.1)

933 (4.3)

332 (3.9)

29 (2.3)

 

 2006

2800 (8.9)

2073 (9.6)

633 (7.5)

94 (7.4)

 

 2007

4205 (13.4)

2731 (12.7)

1270 (14.9)

204 (16.0)

 

 2008

4553 (14.5)

3098 (14.4)

1198 (14.1)

257 (20.2)

 

 2009

4667 (14.9)

3297 (15.3)

1129 (13.3)

241 (18.9)

 

 2010

4798 (15.3)

3348 (15.5)

1230 (14.5)

220 (17.3)

 

 2011

4900 (15.6)

3463 (16.1)

1298 (15.3)

139 (10.9)

 

 2012

3699 (11.8)

2348 (10.9)

1268 (14.9)

83 (6.5)

Â